Over the past few decades, theoretical, correlational and experimental studies have linked increased host diversity to lower levels of pathogen infection (reviewed in REF. 1). This observation initially came from agriculture, where it is known as the monoculture effect 2 , but also applies to animals. For example, natural populations with low levels of genetic diversity (such as endangered species 3 and inbred animals 4 ) tend to have higher pathogen loads, and experimental increases in host diversity result in decreased pathogen abundance 5, 6 . Consistent with these observations, many organisms across the five kingdoms of life have evolved sophisticated diversitygenerating mechanisms (DGMs) that provide benefits to both individuals and populations in the presence of infectious disease. In this Opinion article, we first summarize the mechanistic basis of the most well-known DGMs, which have been studied in detail over the past few decades by immunologists, geneticists and molecular biologists, and highlight unifying concepts across the different immune strategies. We then link these molecular data with insights from evolutionary biology and epidemiology to discuss when and why recombination, whereas the higher levels of diversity that are typically generated by targeted DGMs drive the evolution of more sophisticated anti-DGM strategies as part of an arms race between the host and its pathogens.
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Untargeted DGMs
Untargeted DGMs, which include any mechanism that creates diversity across the entire genome of a host species, are widespread. We discuss how germline mutation and sexual reproduction generate untargeted diversity and detail the selective advantage of these mechanisms when hosts are exposed to pathogens.
Germline mutation. The simplest mechanism for generating genetic diversity between parents and their offspring is through germline mutations, such as single-nucleotide polymorphisms (SNPs), indels, gene duplications, inversions and transposable element insertions (FIG. 1a) . Mutation rates vary between species and between strains of the same species. For example, SNPs are typically generated at frequencies from 10 −7 to 10 −10 base substitutions per nucleotide per generation, which is well above the biochemical limit to proofreading during DNA replication. Whereas it has been suggested that variation in mutation rates between species may result from genetic drift 7 , the selection of beneficial mutations may also help to explain variation within species 8 . Theoretical analyses predict that host-pathogen co-evolution can select for increased mutation rates 9, 10 that allow for the more rapid generation of resistance mutations. Consistent with this prediction, bacteria co-evolving with bacteriophage (phage) frequently evolved 10-to 100-fold increased mutation rates (mutator strains), and these strains were more likely to drive phage to extinction compared with non-mutator strains 10 . Selection for mutator strains increases upon exposure to multiple phage 11 , which may drive the high frequencies of these strains in natural 12, 13 and clinical environments 14 . Although such germline mutations are often thought of as random, mutation frequencies tend to be distributed non-uniformly across genomes as a result different DGMs are particularly beneficial and their broader implications for disease epidemics and host-pathogen co-evolution (that is, their reciprocal adaptation). Understanding the link between these molecular and macroscopic processes can guide future molecular immunology research into the scale of the host diversity of resistance alleles in space and time. Key questions to address involve how much diversity can be generated in one individual and between individuals as well as how such diversity is maintained over time. An increased knowledge of resistance-allele diversity could help to predict the emergence and spread of infectious diseases.
We propose that DGMs can be broadly classified into two groups: those that function across the entire host genome (for example, mutation and sexual reproduction; referred to here as untargeted DGMs) and those that are targeted to specific loci involved in host-pathogen interactions (for example, V(D)J recombination and prokaryotic CRISPRCas; referred to here as targeted DGMs). Untargeted DGMs tend to generate relatively low levels of diversity that pathogens can overcome by genetic mutation or Abstract | Species from all five kingdoms of life have evolved sophisticated mechanisms to generate diversity in genes that are involved in host-pathogen interactions, conferring reduced levels of parasitism to both individuals and populations. Here, we highlight unifying concepts that underpin these evolutionarily unrelated diversity-generating mechanisms (DGMs). We discuss the mechanisms of and selective forces acting on these diversity-generating immune strategies, as well as their epidemiological and co-evolutionary consequences. We propose that DGMs can be broadly classified into two classes -targeted and untargeted DGMs -which generate different levels of diversity with important consequences for host-parasite co-evolution. of nucleotide composition and genomic context 15, 16 , gene transcription 17, 18 and chromatin organization [19] [20] [21] . The existence of mutational hot and cold spots across genomes has selected for genes that are involved in rapid adaptation (for example, genes associated with pathogen defence) to be located in hot spots, whereas genes that are involved in conserved processes (such as transcription and translation) reside in cold spots 22 .
Sexual reproduction.
A more sophisticated form of untargeted DGM is sexual reproduction. Sex generates populationlevel diversity through recombination during meiosis, which breaks up existing allele combinations and generates novel ones, and (in the case of biparental sexual reproduction) by combining alleles from different individuals in a pathogen Serratia marcescens selects for outcrossing 30 . As is the case for germline mutation, recombination hot spots during sexual reproduction generate relatively large amounts of diversity at genes that are associated with pathogen immunity (for example, MHC genes 31 ). To increase the pathogen resistance of their offspring, females may prefer to mate with males who have optimal resistance alleles 32 . Non-random mating based on MHC genes has been shown for several species (reviewed in REF. 33 ), including mouse and fish 34, 35 . Such mating preferences could be based on chemosensory signals associated with MHC molecules 36 . Other organisms, such as social insects, are thought to lack this mating preference; instead, females may prefer to mate with multiple males to increase heterogeneity among offspring, presumably to decrease disease spread [37] [38] [39] . population during cross-fertilization (FIG. 1b) . In theory, the maintenance of sex as a means of reproduction can be driven by a need to escape pathogens 23, 24 . Specifically, if pathogens are specialized with respect to host genotypes, then sexual reproduction can generate rare genotypes that are susceptible to infection with fewer pathogens in the short term. Many correlational and experimental studies support this idea (reviewed in REF. 25 ). For example, analyses of the distributions of sexual and parthenogenic forms of a freshwater snail (Potamopyrgus antipodarum) show that sexual forms are more common in habitats with high pathogen densities and vice versa [26] [27] [28] . In mixed populations, sexual forms tend to be less frequently infected than asexual forms 29 . In Caenorhabditis elegans, it has been shown that presence of the bacterial Unifying concepts. These examples illustrate how untargeted DGMs generate diversity across genomes and detail their benefits in the presence of infectious disease. However, as these untargeted mechanisms also generate diversity at loci that are not involved in host-pathogen interactions, they can enhance adaptation to other selective pressures, such as environmental change. Therefore, the evolution of untargeted DGMs is not driven by pathogens alone 40 . For example, germline mutation has an important role in adaptation in general, and increased mutation rates are commonly observed in the absence of pathogens 8, 41, 42 . Likewise, sexual reproduction has an important role in adaptation 43 by reducing clonal interference (competition between genotypes that carry different advantageous mutations) and breaking the linkage between beneficial and deleterious mutations 44 , and it helps to maintain population fitness through sexual selection of the fittest males 45 .
Targeted DGMs
Unlike mutation and sexual reproduction, which generate diversity between generations (with the exception of somatic mutations 46 ) and across entire genomes, targeted DGMs can generate diversity upon pathogen exposure specifically in genetic loci that are important for host-pathogen interactions (FIG. 2) . Targeted DGMs generate higher levels of diversity than untargeted DGMs, and this diversity can be generated both between and within hosts.
Vertebrate adaptive immunity. The adaptive immune response of jawed vertebrates involves arguably the most thoroughly studied DGMs 47 . The main sources of diversity are B cells and T cells, which generate large repertoires of B cell receptors (BCRs) and antibodies, and T cell receptors (TCRs), respectively, that can interact with diverse pathogen antigens 48, 49 . As outlined below, the adaptive immune response generates both within-and between-host diversity in the resistance alleles encoding these receptors. Note that -aside from the direct transfer of antibodies from mother to offspring -only the propensity to generate diversity is heritable in this case, not the diverse BCR and TCR resistance alleles themselves (reviewed in REF. 50 ).
One of the key mechanisms in this diversity-generating process is V(D)J recombination, which acts on multi-copy V (variable), J (joining) and sometimes D (diversity) gene segments by semi-randomly incomplete germline VLR alleles through gene conversion to assemble mature VLRs that contain a unique combination of variable LRR modules derived from the hundreds of different LRR modules that flank the germline VLR allele. The diversity, specificity and affinity of VLRs that result from this combinatorial assembly are comparable to those of antigen receptors in jawed vertebrates 66 .
RNA interference. RNA interference (RNAi) has an important role in antiviral immunity in plants and invertebrates [67] [68] [69] [70] [71] , and recent studies proposed a role in mouse embryonic stem cells, which lack a functional interferon response 72, 73 . In antiviral RNAi, an RNaseIII enzyme known as Dicer recognizes and cleaves viral double-stranded RNA into viral small interfering RNA (viRNA) that is typically 21-24 nucleotides in length (FIG. 2b) . These viRNAs are loaded onto Argonaute enzymes, which are a key component linking together single copies of each to generate unique variable antigen-recognition domains 51 (FIG. 2a) . This DGM involves many enzymes, including the hairpin-forming transposase recombination-activating gene 1 (RAG1) and its cofactor RAG2 (REF. 52 ).
High-resolution models of the RAG1-RAG2 protein complex 53 help to explain why mutations in these genes can cause severe combined immunodeficiency 54 . By contrast, in species such as chicken, almost all diversity comes from gene conversion, in which gene segments in the antibody variable region recombine with gene segments from pseudogenes 55 . Following V(D)J recombination, the primary antibody repertoire produced by B cells goes through a process known as affinity maturation, which is mediated by activation-induced cytidine deaminase (AID; also known as AICDA). This process takes place in germinal centres, where B cells undergo repeated cycles of mutation (known as somatic hypermutation) in the variable regions of immunoglobulin genes and selection based on affinity for antigen [56] [57] [58] . Somatic hypermutation can increase antibody affinity by orders of magnitude and, for example, is essential for generating broadly neutralizing antibodies against influenza virus 59 . Although some of the antibody diversity that is generated is inevitably lost during selection as a result of clonal expansion 60 , the extent of this loss is variable, and it has been shown that antibodies with different affinities for the same antigen can coexist in the same host 61, 62 . In addition to mutation of the variable sequence, antibodies also undergo class-switch recombination (CSR), whereby variable regions are linked to genes encoding alternative constant regions (encoding the non-variable parts of the antibody), which results in a switch of antibody class and therefore interactions with different effectors. The type of switch is determined by cytokine levels as well as genetic factors 63 . Lampreys and hagfish are primitive jawless vertebrates that lack BCRs, TCRs and MHC molecules but encode an alternative adaptive immune system that uses antigen receptors termed variable lymphocyte receptors (VLRs) 64 . In their mature form, VLRs are composed of up to eight highly variable leucine-rich repeat (LRR) modules flanked by conserved LRR modules and other conserved sequence elements. Three types of VLR have been identified that are expressed by separate lymphocyte lineages (reviewed in REF. 65 ).
Lymphocytes somatically diversify their

Glossary
Monoculture effect
The increased incidence of diseases in monocultures of the same crop.
Indels
The insertion or deletion of bases in the DNA of an organism.
Transposable element
A DNA sequence that can mobilize to a new position within the genome.
Genetic drift
A change in allele frequencies as a result of the random sampling of gametes that form the next generation.
Parthenogenic
Reproducing in an asexual manner.
Germinal centres
Sites within secondary lymphoid tissue where B cell proliferation, selection and maturation take place during antibody responses.
CRISPR escape phage
Phage that acquire mutations at positions in the protospacer (the sequence matching the CRISPR spacer) or the protospacer adjacent motif (a short DNA sequence required for CRISPR activity) that allow them to overcome CRISPR-Cas immunity.
Arms-race dynamics (ARD). Co-evolutionary dynamics that are characterized by the increase of both host resistance and pathogen infectivity ranges: hosts evolve resistance to a broader range of pathogen genotypes and pathogens evolve infectivity to a broader range of host genotypes.
Fluctuating selection dynamics
(FSD). Co-evolutionary dynamics that are characterized by fluctuations in host and pathogen genotypes owing to frequency dependent selection, whereby the fitness of host genotypes is inversely correlated with their frequency in the population. 75 , but it leads to viRNA diversity within and between individuals. In the absence of such diversity of viRNAs, rapid virus evolution diversity of viRNAs is encoded by the host RNAi genes, but generating resistanceallele diversity does not require any genetic change to the host genome. The sampling d | Type I restriction-modification (RM) systems encode a restriction endonuclease (HsdR), a methylase (HsdM) and a specificity subunit (HsdS). HsdM methylates recognition sequences on the bacterial genome, and HsdR cleaves the same sequences when unmodified (for example, in phage DNA). RM shufflons have a second pseudogene copy of hsdS (and in some cases, up to six pseudogene copies), which can recombine with the main hsdS gene, resulting in altered sequence specificity of the RM system. can overcome RNAi-mediated resistance through mutations of the viral target sequence that disrupt complementarity to the viRNA [76] [77] [78] . As a consequence of the rapid escape of viruses from a single viRNA, the mainstream approach to developing transgenic crops with RNAi-mediated virus resistance depends on the production of multiple viRNAs 79 . CRISPR-Cas. Although some prokaryotes do encode Argonaute enzymes 80 , the main prokaryotic DGM is the CRISPRCas adaptive immune system (FIG. 2c) . CRISPR-Cas systems integrate parasitic DNA sequences (spacers) into CRISPR loci on the host genome 81 , which provides heritable immunity against pathogens with a matching nucleotide sequence. Cas enzymes use processed transcripts of CRISPR loci as guides 82 to mediate the sequence-specific cleavage of (usually) complementary DNA 83 and sometimes RNA 84, 85 , or both [86] [87] [88] . Although the sampling of pathogenderived spacers is often not random 89, 90 , most bacterial clones acquire unique spacers 91 . Hence, CRISPR-Cas systems rapidly generate population-level diversity at CRISPR loci. One study showed that this diversity is an important fitness determinant, as it limits the evolution of CRISPR escape phage, which carry point mutations that allow evasion from the CRISPR-mediated immune response 6 . CRISPR-Cas systems can also generate within-host diversity through the acquisition of multiple spacers from the same pathogen, which also limits the evolution of escape phage 6, 92 . Phase variation. Another example of a bacterial DGM is phase variation, which can generate population-level heterogeneity by switching genes on or off through slipped-strand mispairing, inversions or site-specific recombinations 93 . A key example in bacterial immunity is provided by type I restriction-modification (RM) shufflons (FIG. 2d) . RM systems function through epigenetic modification of specific host DNA sequences and cleavage of the same sequences when unmodified, such as those encoded on phage genomes (reviewed in REF. 94 ). Type I RM shufflons encode specificity subunits (HsdS), which determine the sequence specificity; methylases (HsdM), which catalyse methylation of the corresponding sequences; and restriction endonucleases (HsdR), which catalyse cleavage of these sequences when unmodified. Phage can rapidly evolve to overcome RM systems, for example methyl-directed mismatch repair system, can be selected for based on their linkage with beneficial phage resistance mutations that are generated in the same genetic background; these resistance mutations occur at higher frequencies in mutator strains compared with wild-type bacterial strains because of the increased mutation rate 8 . Other systems, such as RNAi and the adaptive immune response, are also likely to have arisen because of their benefits in terms of an individual's resistance to pathogens, and the within-host diversity that they generate will reduce the probability of pathogens overcoming host defences.
However, theory and data show that host diversity (and therefore DGMs, provided that the diversity that they generate is maintained) can also provide populationlevel benefits. Increased host diversity can decrease the pathogen reproductive rate (epidemiological effect) and can make it more difficult for the pathogen to adapt to the host population (evolutionary effect). As targeted DGMs usually generate higher levels of diversity in resistance genes than do non-targeted DGMs, they provide greater epidemiological and evolutionary benefits in the presence of infectious diseases.
Epidemiological effect. The first populationlevel benefit of host diversity is a reduction in the size of disease epidemics. If host-pathogen interactions are specific (in other words, pathogen genotypes infect a restricted and non-overlapping range of host genotypes), then the reproductive rate of a pathogen is predicted to be larger in homogeneous compared with heterogeneous host populations 106 . This epidemiological effect results from a reduction in the frequency of productive infections (in other words, the host genotypes that can be infected by a particular pathogen genotype become diluted amidst other host genotypes that are not susceptible to infection, which is known as a dilution effect 1 ), as well as an increase in the frequency of failed infections when pathogens infect resistant host genotypes. Above a threshold level of host diversity, the reproductive rate of the pathogen becomes smaller than 1, and it will become extinct unless it can evolve an altered host range.
Evolutionary effect. The diversity of host-resistance alleles is also predicted to limit pathogen evolution because it is more difficult for pathogens to adapt to heterogeneous host populations than to monocultures 23 and because the reduction in pathogen reproductive rate in when HsdM modifies phage sequences before cleavage by HsdR 95, 96 , which enables unchallenged spread of the methylated escape phage through the bacterial population. However, the HsdS in type I RM shufflons can rapidly diversify through recombination between multiple hsdS genes, hence generating population-level diversity in RM specificity 97, 98 . These systems often generate diversity between hosts, but sometimes, when one host encodes multiple HsdS at multiple loci that can be active simultaneously 97 , they can also generate within-host diversity. Both levels of diversity are predicted to limit the evolution and spread of RM escape phage 99 .
Unifying concepts. As outlined above, targeted DGMs tend to generate high levels of diversity, often both between and within hosts. This diversity is exclusively generated in genes involved in host-pathogen interactions, and therefore, these DGMs do not usually provide benefits in the absence of pathogens. However, exceptions in which these DGMs have been co-opted for other processes do exist. For example, RNAi is involved in many processes including gene regulation, epigenetic modification and transposon regulation, and it therefore has a crucial role in organismal homeostasis and phenotypic plasticity 100 . Bacterial CRISPR-Cas systems sometimes also have a role in (virulence) gene regulation 101 , such as bacterial lipoprotein expression by Francisella novicida during infection to avoid triggering a host immune response 102 . Bacterial RM systems can regulate gene expression through epigenetic changes, such as capsule gene expression in Streptococcus pneumoniae, which is a key virulence determinant 103 . However, targeted DGMs usually have specialized roles in immunity, and where they have non-immune functions, their role in immunity may be less important 104 .
Benefits of DGMs
Most DGMs are likely to have evolved because they increase an individual's resistance to pathogens. For example, sexual reproduction can generate rare genotypes that can escape infection with common pathogens 23 , and increased mutation rates in bacteria increase the rate at which mutations that confer resistance to phage are generated 10, 105 . In these cases, DGM-associated genes can increase in frequency together with the beneficial alleles or allele combinations they generate owing to genetic linkage; for example, bacterial mutator alleles, such as mutations in the heterogeneous host populations reduces the evolutionary potential for the pathogen to adapt to the host population 107 . For example, a field study carried out in China that examined the effect of mixing pathogenresistant and -susceptible rice crops found that mixed crops had a greatly decreased severity of rice blast compared with monocultures, and the results suggested that there was reduced pathogen adaptation to the plants' resistance alleles in the long term when the crops were mixed 108 . A laboratory evolution study showed that populationlevel diversity generated by CRISPR-Cas adaptive immune systems limits the evolution of CRISPR escape phage. When bacterial hosts were grown in monoculture, CRISPR escape phage emerged rapidly, but when the same bacterial CRISPR clones were mixed, escape phage were never observed and the phage were driven to extinction 6 . Diversity in terms of antibodies and viRNAs is likely to be associated with similar benefits -in these cases applying to both individuals (owing to within-host diversity) and populations (owing to between-host diversity).
Costs of DGMs
DGMs may be selected against if they carry fitness costs that outweigh their benefits. These costs will differ between DGMs and may be particularly high for untargeted DGMs. For example, most random mutations are either neutral or detrimental, being the underlying cause of various diseases 46, 109 . However, the costs associated with high mutation rates can be alleviated through mechanisms for tissue-specific mutation (for example, in B cells), site-specific mutation (for example, somatic hypermutation of antigen receptor genes) or stress-induced mutation (as occurs in some bacteria) 110 . Sexual reproduction is also associated with a large cost compared with parthenogenesis, the most important cost being the reduced number of offspring per adult, as males do not contribute to reproductive output during sexual reproduction (known as the twofold cost of sex) 111, 112 . Targeted DGMs can be associated with both immunopathological costs, whereby the immune response damages the host, and energetic costs. These costs can be manifested both in the short term (for example, when immunological activity contributes to or worsens disease symptoms (reviewed in REF. 113 )) and in the long term (for example, by decreasing the lifespan of individuals with strong the environment, most notably pathogen density. In the cases of mutation and sexual reproduction, the fitness costs are constitutive, and hence, these DGMs may be selected against in the absence of pathogens 122 . This is consistent with the observation that sexually reproducing snails are more abundant in environments with high pathogen densities (discussed above). By contrast, targeted DGMs tend to have relatively low fitness costs in the absence of pathogens and are therefore less likely to be strongly selected against when pathogens are absent 91 .
DGM-associated co-evolution
The individual-and population-level benefits of DGMs indicate that pathogens that are unable to evolve to overcome host resistance owing to genetic constraints, such as their smaller genome size 123 , may become extinct. For example, during co-evolution between the bacterium Pseudomonas fluorescens and its phage under laboratory conditions, host resistance and pathogen infectivity increase over time in a process known as arms-race dynamics (ARD). This process is associated with selective sweeps of host and pathogen genotypes with increased resistance and infectivity, which become rapidly fixed in the population 124 , resulting in the maintenance of low levels of host and pathogen diversity. An increase in the bacterial mutation rate resulting from mutations in the methyl-directed mismatch repair system allows bacteria to outpace the phage, as it becomes increasingly difficult for the phage to adapt to the most common but immune responses 114 ). Minimizing these costs has probably had an important role in shaping the evolution of immune systems (reviewed in REF. 113 ). For example, the production and disposal of large numbers of B and T cells owing to non-productive gene rearrangements during V(D)J recombination and CSR impose an energetic cost on the individual, which has led to the evolution of specific mechanisms to reduce the frequency of deleterious conformations, such as orientation-specific joining of gene fragments in the same transcriptional orientation 115 . In the case of CRISPR-Cas, the immune response is associated with a fitness cost that is induced upon infection, which may be an energetic cost as a result of induced expression of CRISPR-Cas or an immunopathological cost owing to self-reactivity, or it could result from pathogen-induced damage to the host before pathogen clearance 91, 116 . Fitness costs resulting from immunopathology are frequently observed in the context of vertebrate immune systems 117, 118 , as well as bacterial innate 119 and adaptive 120 immune systems. One example of immunopathology associated with the antibody response is that which is mediated by RAG1. During V(D)J recombination, RAG1 often binds cryptic recombination sequences in nonimmunoglobulin sequences, leading to genome instability; the cost of this is mitigated by reducing the genome-wide frequency of such sites 121 . Whether the benefits of a particular DGM outweigh the costs will depend on , resulting in an increased probability of phage extinction 10 . However, in other cases, the diversity of host resistance alleles and pathogen infectivity alleles is maintained in the population, and host resistance can be quite specific for particular pathogen genotypes 125, 126 . Indeed, this assumption is crucial to explain pathogen-mediated maintenance of sexual reproduction 23, 24 . In this case, pathogens would typically adapt to counter resistance of the most common host genotype 127 . This would provide an advantage to rare host genotypes 128 , which theoretically leads to ongoing co-evolution between the host and pathogen through fluctuating selection dynamics (FSD), whereby fitness and therefore frequencies of host and pathogen genotypes fluctuate over time 23 . Co-evolutionary FSDs have been observed in several host-pathogen interactions 129, 130 . Unlike ARD, FSD-type co-evolution can in theory continue indefinitely, which allows for the maintenance of host and pathogen diversity.
However, not all DGMs that generate high levels of diversity will cause FSD-type co-evolution. In addition to the requirement for a high specificity of infection (discussed above), pathogens need to be able to adapt to a common host genotype for FSD to occur. This depends both on the molecular mechanism of the DGM (for example, genetic constraints on the pathogen to overcome host resistance will be different for an antibody response, where pathogens need to evolve a modified epitope, compared with RNAi or CRISPR-Cas, where a SNP in the target sequence leads to escape) and on the levels of host diversity that are generated. In the case of untargeted DGMs, which generate relatively low levels of diversity, pathogen adaptations by mutation or recombination alone are often sufficient to overcome host resistance. As discussed above, the high levels of diversity generated by targeted DGMs can limit pathogen adaptation by mutation, resulting in pathogen extinction 6 . For example, despite the rapid evolution of CRISPR escape phage 131 and the high specificity of interactions between CRISPR-mediated resistant hosts and escape phage (one escape phage can infect only a single CRISPR-mediated resistant clone) 132 , FSD-type co-evolution is not observed owing to the high levels of CRISPR diversity 6, 133 , which limit the ability of phage to adapt to dominant and anti-CRISPR proteins 145 (FIG. 3e) .
The latter were first discovered in Pseudomonas phage 145 but are now recognized to be extremely widespread, to have little sequence similarity 146 and to be mechanistically diverse [147] [148] [149] . The evolution of anti-DGM strategies by pathogens can result in an arms race with the host that takes place over long evolutionary timescales, whereby hosts continuously evolve to escape anti-DGM activity and pathogens evolve to increase anti-DGM activity. Indeed, genes that are involved in antiviral RNAi are among the most rapidly evolving genes in the Drosophila genome 150 . Such co-evolutionary interactions are likely to have an important role in shaping immune systems, including their genetic and functional diversification.
Conclusion and future prospects
Many hosts encode DGMs that are involved in host-pathogen interactions. Here, we propose that although their molecular mechanisms are diverse, many DGMs have common features with regards to their selective benefits and epidemiological and co-evolutionary consequences. Understanding the link between these microscopic and macroscopic processes will be important for designing effective public-health strategies to prevent or limit the emergence of infectious diseases. Vaccination programmes and crop protection strategies in agriculture rely on increasing the proportion of resistant hosts in the population, but they often do not take into account the diversity of resistance alleles. Most of our current understanding of the interaction between diversity and disease relies on theoretical models, but many of these models have not been experimentally validated. Future work aimed at understanding how environmental variables such as pathogen diversity and population structure impact the benefits of host diversity will be an important step forward in our understanding of the evolutionary epidemiology of pathogens, which can help to develop durable strategies to control human, plant and animal disease. Understanding the epidemiological and evolutionary implications of resistance-allele diversity may also guide further molecular studies to improve our understanding of how diversity in resistance alleles, such as antibodies and small RNA molecules, is generated and the scale at which diversity is maintained over time both within and between individuals. host genotypes. This relationship, in turn, imposes a strong selection pressure on pathogens to evolve more sophisticated strategies to evade host immunity. As the evolution of such anti-DGM strategies requires genetic innovation, this process occurs over longer timescales as part of an arms race between hosts and pathogens.
Evolution of anti-DGM strategies. One way in which pathogens can escape the host resistance mediated by targeted DGMs that generate high levels of diversity is by evolving high levels of diversity themselves. Probably the best-known example of this is capsule switching in the human pathogen Streptococcus pneumoniae, which allows the pathogen to evade the human immune system during infection 134 . Another example is antigenic variation in Trypanosoma brucei, the causative agent of sleeping sickness, which has approximately 1,000 copies of the variant-specific glycoprotein (VSG) gene that encodes the main surface antigen (FIG. 3a) . Each pathogen expresses only one VSG gene and the immune response targets the most abundant VSG genotype, which allows rarer genotypes to evade the immune response 135 . Similarly, Plasmodium falciparum, the human malaria pathogen, encodes a large number of var genes, which are differentially expressed in different pathogen lines. These genes encode surface proteins responsible for antigen variation in infected red blood cells, which are key determinants of immune evasion and virulence 136 . Other examples include influenza virus reassortment 137 (FIG. 3b) and diversity-generating retroelements found in the tail genes of phage 138, 139 (FIG. 3c) . In the case of the nematode Strongyloides ratti, pathogen sexual reproduction helps the pathogen to adapt to the host immune system; compared with wild-type rats, the infection of immunocompromised rats is characterized by a decreased proportion of facultatively sexual S. ratti 140 . A second common strategy by which pathogens can escape host resistance is through the evolution of pathogen-encoded mechanisms that specifically antagonize host DGMs. For example, anti-DGM strategies seem to be nearly ubiquitous in plant viruses, which almost invariably encode antiviral silencing suppression genes that interfere with the RNAi pathway (reviewed in REF. 141) (FIG. 3d) . Many vertebrate parasites and pathogens also encode proteins that block the immune response 142, 143 , and many bacteriophage encode anti-RM 144 
